Comparison of Misoprostol and Manual Vacuum Aspirator for Managing Early Pregnancy Miscarriage: Managing Early Miscarriage

Hina Pirzada; Nosheena Shabbir; Saima saeed; Amina Anwar; Uzma Khawaja; Hina Sarwar

doi:10.54393/pjhs.v5i05.1437

Authors

Hina Pirzada Department of Gynecology, Combined Military Hospitals, Muzaffarabad, Pakistan
Nosheena Shabbir Department of Gynecology, Combined Military Hospitals, Muzaffarabad, Pakistan
Saima saeed Department of Gynecology, Combined Military Hospitals, Muzaffarabad, Pakistan
Amina Anwar Department of Gynecology, Combined Military Hospitals, Muzaffarabad, Pakistan
Uzma Khawaja Department of Gynecology, Combined Military Hospitals, Muzaffarabad, Pakistan
Hina Sarwar Department of Gynecology, District Head Quarter Hospital Jhelum Valley, Jhelum, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v5i05.1437

Keywords:

Miscarriage, Manual Vacuum Aspirator, Misoprostol

Abstract

Manual vacuum aspiration is a safe and effective technology for the treatment of incomplete miscarriage but it is not widely available and affordable in rural areas particularly in low-resource countries. Objective: To compare efficacy, safety and acceptability of misoprostol and manual vacuum aspirator in management of early pregnancy miscarriage Methods: Prospective quasi experimental study Department of gynecology and obstetrics, Sheikh Khalifa Bin Zayed Al Nahyan (CMH).Muzaffar Abad. Study duration was 6 months. A sample of 90 women was calculated using WHO calculator. Patients were approached through non probability consecutive sampling. After following inclusion and exclusion criteria, Patients were randomly divide into two groups; Group A was given misoprostol while group B was patients underwent manual vacuum aspiration. Data were analyzed with SPSS version 25.0. Chi-square and fissure exact test was applied. Results: Total 90 patients were included in study. Mean age of patients was 35.4 ± 3.2SD. Treatment failure/incomplete uterine evacuation was significantly lower in manual vacuum aspiration group as compared to misoprostol group (45.6% vs 36.7%, p=0.05). Misoprostol showed less adverse events (p=0.03) and high satisfaction rate (p=0.00) as compared to manual vacuum aspirator. Conclusions: Manual vacuum aspirator is more effective in complete uterine evacuation as compared to misoprostol. However, misoprostol is found as more safe with limited side effects and highly acceptable drug as compared to manual vacuum aspirator. It is recommended to use misoprostol as a better choice for management of early pregnancy loss in resource limited areas

References

Farquharson RG, Jauniaux E, Exalto N. Updated and revised nomenclature for description of early pregnancy events. Human Reproduction. 2005 Nov; 20(11): 3008-11. doi: 10.1093/humrep/dei167. DOI: https://doi.org/10.1093/humrep/dei167

Soltanghoraee H, Mohazzab A, Soltani A, Ansaripour S, Tavakoli M, Rafati M et al. Histological Evaluation of Products of Conception, Who Benefits from It?. Fetal and Pediatric Pathology. 2023 Jan; 42(1): 30-43. doi: 10.1080/15513815.2022.2053916. DOI: https://doi.org/10.1080/15513815.2022.2053916

Nwafor JI, Agwu UM, Egbuji CC, Ekwedigwe KC. Misoprostol versus manual vacuum aspiration for treatment of first trimester incomplete miscarriage in a low resource setting: A randomized controlled trial. Nigerian Journal of Clinical Practice. 2020 May 18; 23(5): 638-46. doi: 10.4103/njcp.njcp_379_19. DOI: https://doi.org/10.4103/njcp.njcp_379_19

Kanmaz AG, İnan AH, Beyan E, Budak A. The effects of threatened abortions on pregnancy outcomes. Ginekologia Polska. 2019 Mar; 90(4): 195-200. doi: 10.5603/GP.a2019.0035. DOI: https://doi.org/10.5603/GP.a2019.0035

Baranovskaya EI. Maternal mortality in modern world. Obstetrics, Gynecology and Reproduction. 2022 Jul; 16(3): 296-305. doi: 10.17749/2313-7347/ob.gyn.rep.2022.279. DOI: https://doi.org/10.17749/2313-7347/ob.gyn.rep.2022.279

Kyejo W, Moshi B, Kapesi V, Ntiyakunze G, Gidion D, Kaguta M. Cervical vasovagal shock: A rare complication of incomplete abortion case report. International Journal of Surgery Case Reports. 2022 Aug; 97: 107455. doi: 10.1016/j.ijscr.2022.107455. DOI: https://doi.org/10.1016/j.ijscr.2022.107455

Chu JJ, Devall AJ, Beeson LE, Hardy P, Cheed V, Sun Y et al.. Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial. The Lancet. 2020 Sep; 396(10253): 770-8. doi: 10.1016/S0140-6736(20)31788-8. DOI: https://doi.org/10.1016/S0140-6736(20)31788-8

Ehrnstén L, Altman D, Ljungblad A, Kopp Kallner H. Efficacy of mifepristone and misoprostol for medical treatment of missed miscarriage in clinical practice—a cohort study. Acta Obstetricia et Gynecologica Scandinavica. 2020 Apr; 99(4): 488-93. doi: 10.1111/aogs.13780 DOI: https://doi.org/10.1111/aogs.13780

Ibiyemi KF, Munir'deen AI, Adesina KT. Randomised trial of oral misoprostol versus manual vacuum aspiration for the treatment of incomplete abortion at a Nigerian Tertiary Hospital. Sultan Qaboos University Medical Journal. 2019 Feb; 19(1): e38. doi: 10.18295/squmj.2019.19.01.008. DOI: https://doi.org/10.18295/squmj.2019.19.01.008

Khaniya B and Yadav R. Comparison of use of misoprostol versus manual vacuum aspiration in the treatment of incomplete abortion. Nepalese Medical Journal. 2019 Dec; 2(2): 239-42. doi: 10.3126/nmj.v2i2.25855. DOI: https://doi.org/10.3126/nmj.v2i2.25855

Diener ED, Emmons RA, Larsen RJ, Griffin S. The satisfaction with life scale. Journal of Personality Assessment. 1985 Feb; 49(1): 71-5. doi: 10.1207/s15327752jpa4901_13. DOI: https://doi.org/10.1207/s15327752jpa4901_13

Musarandega R, Nyakura M, Machekano R, Pattinson R, Munjanja SP. Causes of maternal mortality in Sub-Saharan Africa: a systematic review of studies published from 2015 to 2020. Journal of Global Health. 2021 Oct; 11: 04048. doi: 10.7189/jogh.11.04048. DOI: https://doi.org/10.7189/jogh.11.04048

Ani VC, Enebe JT, Dim CC, Dim NR, Ozumba BC. Sublingual misoprostol versus manual vacuum aspiration for treatment of incomplete abortion in Nigeria: a randomized control study. Pan African Medical Journal. 2022 Feb; 41(90). doi: 10.11604/pamj.2022.41.90.29364. DOI: https://doi.org/10.11604/pamj.2022.41.90.29364

Shwekerela B, Kalumuna R, Kipingili R, Mashaka N, Westheimer E, Clark W et al. Misoprostol for treatment of incomplete abortion at the regional hospital level: results from Tanzania. BJOG: An International Journal of Obstetrics and Gynaecology. 2007 Nov; 114(11): 1363-7. doi: 10.1111/j.1471-0528.2007.01469.x. DOI: https://doi.org/10.1111/j.1471-0528.2007.01469.x

Niinimäki M, Jouppila P, Martikainen H, Talvensaari-Mattila A. A randomized study comparing efficacy and patient satisfaction in medical or surgical treatment of miscarriage. Fertility and Sterility. 2006 Aug; 86(2): 367-72. doi: 10.1016/j.fertnstert.2005.12.072. DOI: https://doi.org/10.1016/j.fertnstert.2005.12.072

Weeks A, Alia G, Blum J, Winikoff B, Ekwaru P, Durocher J et al. A randomized trial of misoprostol compared with manual vacuum aspiration for incomplete abortion. Obstetrics and Gynecology. 2005 Sep; 106(3): 540-7. doi: 10.1097/01.AOG.0000173799.82687.dc. DOI: https://doi.org/10.1097/01.AOG.0000173799.82687.dc

Musik T, Grimm J, Juhasz-Böss I, Bäz E. Treatment options after a diagnosis of early miscarriage: expectant, medical, and surgical. Deutsches Ärzteblatt International. 2021 Nov; 118(46): 789. doi: 10.3238/arztebl.m2021.0346. DOI: https://doi.org/10.3238/arztebl.m2021.0346

Elati A and Weeks A. Risk of fever after misoprostol for the prevention of postpartum hemorrhage: a meta-analysis. Obstetrics and Gynecology. 2012 Nov; 120(5): 1140-8. doi: 10.1097/AOG.0b013e3182707341. DOI: https://doi.org/10.1097/AOG.0b013e3182707341

Bique C, Usta M, Debora BE, Chong E, Westheimer E, Winikoff B. Comparison of misoprostol and manual vacuum aspiration for the treatment of incomplete abortion. International Journal of Gynecology and Obstetrics. 2007 Sep; 98(3): 222-6. doi; 10.1016/j.ijgo.2007.05.003. DOI: https://doi.org/10.1016/j.ijgo.2007.05.003

Dao B, Blum J, Thieba B, Raghavan S, Ouedraego M, Lankoande J et al. Is misoprostol a safe, effective and acceptable alternative to manual vacuum aspiration for postabortion care? Results from a randomised trial in Burkina Faso, West Africa. BJOG: An International Journal of Obstetrics and Gynaecology. 2007 Nov; 114(11): 1368-75. doi: 10.1111/j.1471-0528.2007.01468.x. DOI: https://doi.org/10.1111/j.1471-0528.2007.01468.x

Dabash R, Ramadan MC, Darwish E, Hassanein N, Blum J, Winikoff B. A randomized controlled trial of 400-μg sublingual misoprostol versus manual vacuum aspiration for the treatment of incomplete abortion in two Egyptian hospitals. International Journal of Gynecology and Obstetrics. 2010 Nov; 111(2): 131-5. doi: 10.1016/j.ijgo.2010.06.021. DOI: https://doi.org/10.1016/j.ijgo.2010.06.021